Author: Zhichao Feng; Jennifer Li; Shanhu Yao; Qizhi Yu; Wenming Zhou; Xiaowen Mao; Huiling Li; Wendi Kang; Xin Ouyang; Ji Mei; Qiuhua Zeng; Jincai Liu; Xiaoqian Ma; Pengfei Rong; Wei Wang
Title: The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis Document date: 2020_4_10
ID: k65501xp_39
Snippet: Our study examined the controversial topic of COVID-19 and ACEI/ARB therapy in hypertensive patients. We found that hypertensive patients on ACEI/ARB therapy were less likely to develop severe pneumonia, although we acknowledged that the analysis was conducted in limited sample size -with only 16 of 82 patients on ACEI/ ARB therapy. The dynamic profile of laboratory and radiological findings further showed that in patient on ACEI/ARB therapy, lac.....
Document: Our study examined the controversial topic of COVID-19 and ACEI/ARB therapy in hypertensive patients. We found that hypertensive patients on ACEI/ARB therapy were less likely to develop severe pneumonia, although we acknowledged that the analysis was conducted in limited sample size -with only 16 of 82 patients on ACEI/ ARB therapy. The dynamic profile of laboratory and radiological findings further showed that in patient on ACEI/ARB therapy, lactose dehydrogenase and CT lung score were lower in than those on non-ACEI/ARB therapy at about 3 days after admission. Together, these findings were suggestive that ACEI/ ARB therapy may be protective in hypertensive patients with COVID-19.
Search related documents:
Co phrase search for related documents- ACEI ARB therapy and non acei ARB therapy: 1, 2, 3, 4
- ACEI ARB therapy and sample size: 1
- ARB therapy and non acei ARB therapy: 1, 2, 3, 4
- CT lung score and lung score: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- hypertensive patient and lung score: 1
Co phrase search for related documents, hyperlinks ordered by date